Back
T
Teebah Abu-Zahra
department of clinical epidemiology and medical technology assessment
2H-index
19Paper Count
24Citation Count
Published Papers 4
Publication Date
Accounting for Genomic Testing Costs in Cost-Effectiveness Evaluations: Challenges and Lessons Learned from the NICE Single Technology Appraisal of Erdafitinib for Treating Unresectable or Metastatic Urothelial Cancer with FGFR3 Alterations After a PD-1 or PD-L1 Inhibitor
PharmacoEconomics
IF4.6

